NIH RFA · NIDDK · P30
RFA-DK-26-310: Diabetes Research Centers (P30 Clinical Trial Optional)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P&F), DRCs are intended to create an environment that provides the capability for…
- NOFO number
- RFA-DK-26-310
- Type
- RFA
- Activity code
- P30
- Primary institute
- NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
- Clinical trials
- Optional
- Posted
- Dec 5, 2025
- Opens
- Feb 10, 2026
- Expires
- Jan 28, 2027
RFA-DK-26-310 due dates
1 application due date remains before the NOFO expires. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| March 10, 2026 | March 10, 2026 | Not Applicable | July 2026 | October 2026 | December 2026 |
| January 27, 2027 | January 27, 2027 | Not Applicable | July 2027 | October 2027 | December 2027 |
What its predecessor RFA-DK-25-008 funded
RFA-DK-26-310 reissues RFA-DK-25-008. Until awards appear under the new number, its funding history is the best guide to who wins under this program: 6 projects and $20.4M in FY2022–FY2026.
Projects funded
6
Distinct projects, FY2022–FY2026
New awards
1
Type 1 (new project) award records
NIH funding
$20.4M
Award dollars under RFA-DK-25-008, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 6 | 1 | $10.5M |
| FY2026 | 6 | 0 | $9.9M |
Institutions with the most funding
- Albert Einstein College of Medicine$4.5M · 1 project
- University of California, San Francisco$3.5M · 1 project
- University of California, San Diego$3.4M · 1 project
- Indiana University Indianapolis$3.2M · 1 project
- Wake Forest University Health Sciences$3.1M · 1 project
- University of Colorado Denver$2.6M · 1 project
Funding institutes
- NIDDK$20.4M · 12
Activity codes funded
- P3012 records
Most recent new awards
- UCSF Type 1 Diabetes Research Center (opens NIH RePORTER)
University of California, San Francisco · 1P30DK135103-01A1 · NIDDK · Notice Aug 22, 2025
$1.8MP30
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under RFA-DK-26-310. Contact the program officer at the institute that fits your research before applying.
- NIDDK · National Institute of Diabetes and Digestive and Kidney Diseases
- none
Related notices
NIH lists no related notices for RFA-DK-26-310 yet.
Award terms
- Application types allowed
- New Renewal Resubmission Resubmission applications should have applied previously to RFA-DK-25-008, or for the first receipt date from RFA-DK-26-310 The OER Glossary and the How to Apply - Application Guide provides details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are limited to 1,000,000 per year in direct costs. Applications proposing a Regional/National Shared Research Core or expanded P&F Program as described in the Additional Opportunities for Resource Cores and Programs Section of the NOFO are limited to 1,250,000 per year in direct costs. These budget limits are exclusive of: a) first year equipment costs, b) a National…
- Project period
- The maximum project period is five years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- NIDDK intends to commit 10.4 million in FY 2026 and 7.7 million in FY2027.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of RFA-DK-25-008.
Other open NOFOs for P30
- RFA-DK-27-120Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)NIDDK · next due Oct 20, 2026
- RFA-DK-27-119Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)NIDDK · next due Feb 10, 2027
- PAR-28-090Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)NIAID · next due May 25, 2027
- PAR-27-054Limited Competition: Centers of Biomedical Research Excellence: Development Phase (COBRE-D) (P30 - Clinical Trial Not Allowed)NIGMS · next due Jan 25, 2027
- PAR-27-055Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)NIGMS · next due Jan 25, 2027
- PAR-25-444Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)NCI · next due Jan 25, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.